| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T665 |
0-275 |
Sentence |
denotes |
The Use PUL‐042 inhalation solution to prevent COVID‐19 in adults exposed to SARS‐CoV‐2 Drug: PUL‐042 inhalation solution, drug: placebo COVID‐19 200, all, 18 years and older Treatment Experimental: PUL‐042 inhalation solution, PUL‐042 inhalation solution (20.3 µg Pam2: |
| T666 |
276-342 |
Sentence |
denotes |
29.8 µg ODN/mL) given by nebulization on study days 1,3, 6, and 10 |
| T667 |
343-513 |
Sentence |
denotes |
Placebo comparator: sterile normal saline for inhalation, sterile normal saline for inhalation given by nebulization on study days 1, 3, 6, and 10 II Primary (14 days): |
| T668 |
514-582 |
Sentence |
denotes |
Prevention of COVID‐19 NCT04313023/Not yet recruiting, Apr‐Oct 2020 |
